The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial

Figure 2

Study flowchart. CNI, calcineurin inhibitor; Cr-EDTA, measured glomerular filtration rate by Cr-EDTA clearance.